News & Views
R & D Facility Focused on New Market Sectors
Oct 14 2019 Read 281 Times
In-Vitro diagnostics company EKF Diagnostics has opened a Special Projects Laboratory at its UK Headquarters in Cardiff, which will be focused on developing new applications for its range of products with a view to entering new market sectors. This new laboratory brings the total number of EKF’s worldwide R&D facilities to five, with 25 research staff working at two sites in Germany and two in the USA.
EKF’s Cardiff-based laboratory complements and supports EKF’s other global R&D facilities by focusing on product application development and some aspects of data support. The two new research scientists based there will also investigate how EKF products can bring benefits to new markets beyond healthcare and diagnostics, such as the veterinary, food and brewing industries.
The new laboratory will provide diagnostics sales support through product comparisons and new technology evaluations. Its regulatory support work will include data generation for new territory registrations across the world, as well as claim support for existing products where more data may be required.
“Our new Cardiff-based lab is already assisting our other R&D teams globally, freeing them up to dedicate their time to EKF’s new product development and realisation pipeline,” said Dr Gary Dowthwaite, Special Projects Coordinator, EKF Diagnostics. “For example, they are working on a project to obtain data from animal species using our new Lactate Scout 4 analyser. This will enable EKF to enter the veterinary testing market, as raised lactate levels are indicative of an underlying health condition in small animals.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...
View all digital editions
Jan 29 2020 Tokyo, Japan
Feb 03 2020 Dubai, UAE
Feb 12 2020 Tokyo, Japan
Feb 17 2020 Berlin, Germany
Feb 26 2020 Guanghzou, China